NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. Its principal product offering is based on its Maximum Access Surgery, or MAS platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. 
San Diego, US
Size (employees)
2,300 (est)+5%
NuVasive was founded in 1997 and is headquartered in San Diego, US
Report incorrect company information

NuVasive Office Locations

NuVasive has offices in Singapore, Memphis, Columbia, San Diego and in 9 other locations
San Diego, US (HQ)
7475 Lusk Blvd
Aliso Viejo, US
100 101 Enterprise
Columbia, US
250 10420 Little Patuxent Pkwy
Fairborn, US
1 Herald Square
Memphis, US
101 4670 E Shelby Dr
Kew, AU
620 High St
Show all (13)
Report incorrect company information

NuVasive Financials and Metrics

NuVasive Financials

NuVasive's revenue was reported to be $1.03 b in FY, 2017

Revenue (FY, 2017)

1 b

Gross profit (FY, 2017)

760.5 m

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

81.3 m

Market capitalization (20-Apr-2018)

2.9 b

Cash (31-Dec-2017)

72.8 m
NuVasive's current market capitalization is $2.9 b.
USDFY, 2013Y, 2014Y, 2015FY, 2016FY, 2017


685.2 m762.4 m811.1 m962.1 m1 b

Revenue growth, %


Cost of goods sold

180.5 m182.4 m194.5 m240.1 m269 m

Gross profit

504.7 m580.1 m616.6 m722 m760.5 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


192.4 m202.9 m200.5 m215 b236.2 m239.6 m249.9 m260.6 m247.4 m

Cost of goods sold

45.7 m48.4 m49.2 m54.2 b59.7 m59.2 m61.6 m66.4 m65.6 m

Gross profit

146.7 m154.5 m151.4 m160.8 b176.5 m180.5 m188.3 m194.2 m181.8 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


102.8 m142.4 m192.3 m153.6 m72.8 m

Accounts Receivable


10.9 m21.6 m8.8 m208.2 m247.2 m

Current Assets

536 m705.9 m702.8 m575.4 m559 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


100.6 m110.8 m106.5 m130.7 m88.5 m78.6 m141.3 m270.1 m263.1 m203.8 m134 m130.9 m62.2 m

Accounts Receivable

96.2 m


140.7 m147.7 m157.4 m159.7 m163.4 m163.7 m164.9 m200.7 m201.9 m212.8 m223.1 m236.8 m249 m

Current Assets

488 m606.3 m587.1 m629.6 m632.9 m684.3 m698.5 m692.2 m712 m616.9 m563.3 m592.2 m529.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

7 m(17.5 m)65.3 m35.4 m81.3 m

Depreciation and Amortization

63.1 m65.8 m65.9 m42 m121.2 m


(3.6 m)(5.2 m)1.2 m(22.6 m)(35.3 m)

Accounts Payable

(5.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m24.6 m57.7 m

Depreciation and Amortization

16.1 m32.6 m49 m21.2 m46.3 m73.8 m29.5 m58.7 m88.9 m


157.4 m159.7 m(11.4 m)(15.2 m)(19.8 m)(9.4 m)(12 m)(22.4 m)(13.6 m)(29 m)(36.2 m)

Cash From Operating Activities

26 m35.2 m48 m57.4 m100.2 m96 m28 m67.1 m118.9 m
USDY, 2017


468 k

Financial Leverage

2.1 x
Show all financial metrics

NuVasive Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
SafePassage December 12, 2017
Biotronic NeuroNetwork June 06, 2016$98 m
Ellipse Technologies January 05, 2016$410 m
Report incorrect company information

NuVasive News and Updates

Sports Medicine Market: Positive Long -Term Growth Outlook 2016 – 2024

Growing activity in sports and athletic activity among young population is the major factor driving growth of the global sports medicine market. Posted via Industry Today. Follow us on Twitter @IndustryToday

Biological Implants 2018 Global Market Key Players - Integra LifeSciences Corporation, Edwards LifeSciences Corporation, NuVasive, Inc,

Wiseguyreports.Com Adds “Biological Implants – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Cervical Total Disc Replacement Device Market is Expected to be worth US$ 1,750.1 Mn by 2021

Revenue contribution by CTDR device market to the global total disc replacement market is expected to increase to US$ 1,750.1 by the end of 2021, expanding at a CAGR of 23.1% during 2015–2021. Posted via Industry Today. Follow us on Twitter @IndustryToday

Growing Industry of Intraoperative Neurophysiological Monitoring Market: Globally is Estimated to Reach 1.1 Billion With ~8.9% CAGR by 2027

Intraoperative Neurophysiological Monitoring Market Information, by type (EEG, EMG, Evoked Potential (EP)) by Method (Invasive, Non-Invasive, Minimally Invasive) by Source (In-house, Outsource, Tele-Health), by Procedure – Global Forecast to 2027 Posted via Industry Today. Follow us on Twitter @Indu…

Spinal Fusion Market Projected to Register 5.4% CAGR through 2017-2027

Future Market Insights has announced the addition of the “Spinal Fusion Market: Global Industry Analysis and Opportunity Assessment 2017 - 2027" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

World Artificial Disc Replacement Market is Growing at a CAGR of 15 % During Forecasted Period 2017-2023

Market Research Future published a half-cooked research report on global artificial disc replacement market, Global Artificial Disc Replacement Market Is Growing At A CAGR Of 15 % During Forecasted Period 2017-2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information